Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | AHR | P35869 | 1/20 | 0.49 |
| ▸ | GAK | O14976 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16314448 | 0.94 | THRA (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19612285 | 0.94 | MAPT (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL15450963 | 0.92 | CA2 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19612480 | 0.89 | PLA2G4B (0.58) | THRATHRBPLA2G4BLMNAHTT | |
| SCHEMBL9211531 | 0.86 | CA2 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18784001 | 0.86 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16726537 | 0.85 | CA2 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL22498547 | 0.85 | CA2 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13784819 | 0.85 | THRA (0.47) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4392307 | 0.85 | CA2 (0.55) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-11209320-A | — | — | None | — | — | JP | disclosed |
| US-20220153669-A1 | CELLULOSIC COMPLEX AND APPLICATIONS THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2022-05-19 | — | — | US | disclosed |
| WO-2020202179-A1 | CELLULOSIC COMPLEX AND APPLICATIONS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2020-10-08 | — | — | WO | disclosed |
| EP-3097103-B1 | DIAZABICYCLO[4.3.1]DECANE DERIVATIVES FOR TREATMENT OF PSYCHIATRIC DISORDERS | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WSS (DE) | 2017-11-15 | — | — | EP | disclosed |
| JP-H11209320-A | VERATRYL ALCOHOL DERIVATIVE | KAO CORP | 1999-08-03 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153669-A1 | CELLULOSIC COMPLEX AND APPLICATIONS THEREOF | CEL, DBF4, NAF1 | CA12 187/4885CA1 675/4885CA2 329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.